Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer

Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer

10.1177/17407745211009547

Saved in:
Bibliographic Details
Main Authors: Schaffer, Elisabeth M, Basch, Ethan M, Schwab, Gisela M, Bennett, Antonia V
Other Authors: DUKE-NUS MEDICAL SCHOOL
Format: Article
Published: SAGE Publications 2023
Subjects:
Mental recall
randomized phase 3 drug trial
cancer pain
patient-reported outcome
Online Access:https://scholarbank.nus.edu.sg/handle/10635/239598
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-239598
record_format dspace
spelling sg-nus-scholar.10635-2395982023-08-29T21:43:23Z Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer Schaffer, Elisabeth M Basch, Ethan M Schwab, Gisela M Bennett, Antonia V DUKE-NUS MEDICAL SCHOOL Mental recall randomized phase 3 drug trial cancer pain patient-reported outcome 10.1177/17407745211009547 Clinical Trials 18 4 408-416 2023-05-22T01:45:50Z 2023-05-22T01:45:50Z 2021-08 2023-05-19T07:46:29Z Article Schaffer, Elisabeth M, Basch, Ethan M, Schwab, Gisela M, Bennett, Antonia V (2021-08). Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer. Clinical Trials 18 (4) : 408-416. ScholarBank@NUS Repository. https://doi.org/10.1177/17407745211009547 1740-7745 1740-7753 https://scholarbank.nus.edu.sg/handle/10635/239598 SAGE Publications Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic Mental recall
randomized phase 3 drug trial
cancer pain
patient-reported outcome
spellingShingle Mental recall
randomized phase 3 drug trial
cancer pain
patient-reported outcome
Schaffer, Elisabeth M
Basch, Ethan M
Schwab, Gisela M
Bennett, Antonia V
Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer
description 10.1177/17407745211009547
author2 DUKE-NUS MEDICAL SCHOOL
author_facet DUKE-NUS MEDICAL SCHOOL
Schaffer, Elisabeth M
Basch, Ethan M
Schwab, Gisela M
Bennett, Antonia V
format Article
author Schaffer, Elisabeth M
Basch, Ethan M
Schwab, Gisela M
Bennett, Antonia V
author_sort Schaffer, Elisabeth M
title Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer
title_short Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer
title_full Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer
title_fullStr Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer
title_full_unstemmed Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer
title_sort comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer
publisher SAGE Publications
publishDate 2023
url https://scholarbank.nus.edu.sg/handle/10635/239598
_version_ 1779155716851892224

Similar Items